Medicament containing pemafibrate

27:

• A method of treating a liver cirrhosis patient with pemafibrate, comprising administering a medicament comprising pemafibrate, a salt thereof, or a solvate thereof at a dose lower than the dose for a person with normal liver function.

28:

• The method according to claim 27, for treating at least one disease selected from the group consisting of hyperlipemia, dyslipidemia, dyslipidemia, arterial sclerosis, diabetes mellitus, diabetic complications, inflammation, non-alcoholic steatohritis, primary biliary circulation and heart disease.

29:

• The method according to claim 27, wherein the medicament comprising pemafibrate, a salt thereof, or a solvate thereof is a medicament comprising pemafibrate.

30:

• The method according to claim 27, comprising administering the medicament to a mild liver cirrhosis patient at a dose of ½ or less of the dose for a person with normal liver function.

31:

• The method according to claim 27, comprising administering the medicament as 0.1 mg to 0.2 mg of pemafibrate per day to a mild liver cirrhosis patient.

32:

• The method according to claim 27, comprising administering the medicament as 0.05 mg of pemafibrate twice per day to a mild liver cirrhosis patient.

33:

• The method according to claim 27, comprising administering the medicament as 0.1 mg of pemafibrate twice per day to a mild liver cirrhosis patient.

34:

• The method according to claim 27, comprising administering the medicament to a moderate liver cirrhosis patient at a dose of ¼ or less of the dose for a person with normal liver function.

35:

• The method according to claim 27, comprising administering the medicament as 0.05 mg to 0.1 mg of pemafibrate per day to a moderate liver cirrhosis patient.

36:

• The method according to claim 27, comprising administering the medicament as 0.025 mg of pemafibrate twice per day to a moderate liver cirrhosis patient.

37:

• The method according to claim 27, comprising administering the medicament as 0.05 mg of pemafibrate twice per day to a moderate liver cirrhosis patient.